These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7902537

  • 1. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
    Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, Buckley S.
    Nature; 1993 Dec 02; 366(6454):473-5. PubMed ID: 7902537
    [Abstract] [Full Text] [Related]

  • 2. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R.
    Cancer J Sci Am; 1997 Dec 02; 3(1):21-30. PubMed ID: 9072304
    [Abstract] [Full Text] [Related]

  • 3. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H, Riese DJ, Gilbert W, Stern DF, McMahan UJ.
    Nature; 1997 May 29; 387(6632):509-12. PubMed ID: 9168114
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor.
    Culouscou JM, Plowman GD, Carlton GW, Green JM, Shoyab M.
    J Biol Chem; 1993 Sep 05; 268(25):18407-10. PubMed ID: 7689552
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
    Gilbertson RJ, Perry RH, Kelly PJ, Pearson AD, Lunec J.
    Cancer Res; 1997 Aug 01; 57(15):3272-80. PubMed ID: 9242460
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 8. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
    Chan SD, Antoniucci DM, Fok KS, Alajoki ML, Harkins RN, Thompson SA, Wada HG.
    J Biol Chem; 1995 Sep 22; 270(38):22608-13. PubMed ID: 7673253
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 22; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation.
    De Potter IY, Poumay Y, Squillace KA, Pittelkow MR.
    Exp Cell Res; 2001 Dec 10; 271(2):315-28. PubMed ID: 11716544
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP.
    Mol Carcinog; 1996 Mar 10; 15(3):227-38. PubMed ID: 8597535
    [Abstract] [Full Text] [Related]

  • 14. HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins.
    Culouscou JM, Carlton GW, Aruffo A.
    J Biol Chem; 1995 May 26; 270(21):12857-63. PubMed ID: 7759543
    [Abstract] [Full Text] [Related]

  • 15. Bioactive synthetic peptide of NDF/heregulin.
    Kita Y, Mayer J, Zamborelli T, Hara S, Rohde M, Watson E, Koski R, Ratzkin B, Nicolson M.
    Biochem Biophys Res Commun; 1995 May 16; 210(2):441-51. PubMed ID: 7755620
    [Abstract] [Full Text] [Related]

  • 16. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
    Riese DJ, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF.
    Oncogene; 1996 Jan 18; 12(2):345-53. PubMed ID: 8570211
    [Abstract] [Full Text] [Related]

  • 17. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
    Harris LN, Yang L, Tang C, Yang D, Lupu R.
    Clin Cancer Res; 1998 Apr 18; 4(4):1005-12. PubMed ID: 9563896
    [Abstract] [Full Text] [Related]

  • 18. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G, Fitzpatrick VD, Sliwkowski MX.
    Oncogene; 1997 Sep 18; 15(12):1385-94. PubMed ID: 9333014
    [Abstract] [Full Text] [Related]

  • 19. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
    Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y.
    EMBO J; 1996 Jan 15; 15(2):254-64. PubMed ID: 8617201
    [Abstract] [Full Text] [Related]

  • 20. Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression.
    Jo SA, Zhu X, Marchionni MA, Burden SJ.
    Nature; 1995 Jan 12; 373(6510):158-61. PubMed ID: 7816098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.